Saumya Tiwari

Dr. Saumya Tiwari

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2019 in Analytical Chemistry
Verified
Journal Article
Closed access
EKEdward D. Kantz
Edward D. Kantz
STSaumya Tiwari
Saumya Tiwari
JWJeramie D. Watrous
Jeramie D. Watrous
SCSusan Cheng
Susan Cheng
MJMohit Jain
Mohit Jain

29 September 2016 in Analytical Chemistry
Verified
Journal Article
Closed access
STSaumya Tiwari
Saumya Tiwari
JRJai Raman
Jai Raman
VRVijaya Reddy
Vijaya Reddy
AGAndrew Ghetler
Andrew Ghetler
RTRichard P. Tella
Richard P. Tella
BRBhargava Rohit
Bhargava Rohit

14 October 2015 in Scientific Reports
Verified
Journal Article
Open access
SMSantosh K. Misra
Santosh K. Misra
HCHuei-Huei Chang
Huei-Huei Chang
PMPrabuddha Mukherjee
Prabuddha Mukherjee
STSaumya Tiwari
Saumya Tiwari
AOAyako Ohoka
Ayako Ohoka
DPDipanjan Pan
Dipanjan Pan
A plethora of nanoarchitectures have been evaluated preclincially for applications in early detection and treatment of diseases at molecular and cellular levels resulted in limited success of their clinical translation. It is important to identify the factors that directly or indirectly affect their use in human. We bring a fundamental understanding of how to adjust the biocompatibility of carbon based spherical nanoparticles (CNPs) through defined chemistry and a vigilant choice of surface functionalities. CNPs of various size are designed by tweaking size (2–250 nm), surface chemistries (positive, or negatively charged), molecular chemistries (linear, dendritic, hyperbranched) and the molecular weight of the coating agents (MW 400–20 kDa). A combination of in vitro assays as tools were performed to determine the critical parameters that may trigger toxicity. Results indicated that hydrodynamic sizes are potentially not a risk factor for triggering cellular and systemic toxicity, whereas the presence of a highly positive surface charge and increasing molecular weight enhance the chance of inducing complement activation. Bare and carboxyl-terminated CNPs did present some toxicity at the cellular level which, however, is not comparable to those caused by positively charged CNPs. Similarly, negatively charged CNPs with hydroxyl and carboxylic functionalities did not cause any hemolysis.

20 May 2015 in Small
Verified
Journal Article
Closed access
PDF file
PMPrabuddha Mukherjee
Prabuddha Mukherjee
SMSantosh K. Misra
Santosh K. Misra
MGMark C. Gryka
Mark C. Gryka
HCHuei-Huei Chang
Huei-Huei Chang
STSaumya Tiwari
Saumya Tiwari
DPDipanjan Pan
Dipanjan Pan

17 June 2017 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
DSDeepak K Singh
Deepak K Singh
OGOmid Gholamalamdari
Omid Gholamalamdari
MJMahdieh Jadaliha
Mahdieh Jadaliha
XLXiao Ling Li
Xiao Ling Li
YLYo-Chuen Lin
Yo-Chuen Lin
KPKannanganattu V Prasanth
Kannanganattu V Prasanth
Breast cancer (BC) is a highly heterogeneous disease, both at the pathological and molecular level, and several chromatin-associated proteins play crucial roles in BC initiation and progression. Here, we demonstrate the role of PSIP1 (PC4 and SF2 interacting protein)/p75 (LEDGF) in BC progression. PSIP1/p75, previously identified as a chromatin-adaptor protein, is found to be upregulated in basal-like/triple negative breast cancer (TNBC) patient samples and cell lines. Immunohistochemistry in tissue arrays showed elevated levels of PSIP1 in metastatic invasive ductal carcinoma. Survival data analyses revealed that the levels of PSIP1 showed a negative association with TNBC patient survival. Depletion of PSIP1/p75 significantly reduced the tumorigenicity and metastatic properties of TNBC cell lines while its over-expression promoted tumorigenicity. Further, gene expression studies revealed that PSIP1 regulates the expression of genes controlling cell-cycle progression, cell migration and invasion. Finally, by interacting with RNA polymerase II, PSIP1/p75 facilitates the association of RNA pol II to the promoter of cell cycle genes and thereby regulates their transcription. Our findings demonstrate an important role of PSIP1/p75 in TNBC tumorigenicity by promoting the expression of genes that control the cell cycle and tumor metastasis.

5 February 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
STSaumya Tiwari
Saumya Tiwari
AKAndre Kajdacsy-Balla
Andre Kajdacsy-Balla
JWJoshua Whiteley
Joshua Whiteley
GCGeorgina Cheng
Georgina Cheng
SHStephen M Hewitt
Stephen M Hewitt
BRBhargava Rohit
Bhargava Rohit
All-digital infrared spectroscopic imaging of tumors and their microenvironments predicts colon cancer patient survival.